跳至主要内容
临床试验/NCT00856414
NCT00856414已完成4 期

Patient Satisfaction With Treatment of BOTOX® Cosmetic for the Temporary Correction of Moderate to Severe Glabellar Lines

Allergan2 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2009年3月1日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
Allergan
入组人数
45
试验地点
2
主要终点
The First Visit Onset of Efficacy as Measured by Subject Assessment

研究概览

简要总结

This study evaluates the patient satisfaction and onset of effect following treatment with botulinum toxin Type A in the treatment of glabellar rhytids (frown lines)

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
35 Years 至 55 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Female subjects of any race, 35-55 years of age
  • Moderate to severe glabellar wrinkles (lines between the eyebrows)

排除标准

  • Previous botulinum toxin therapy
  • Subjects who are pregnant, breast-feeding, or who are of childbearing potential and not practicing a reliable method of birth control
  • Subjects planning a facial cosmetic procedure or visible scars
  • Previous cosmetic surgery to the upper face
  • Medical condition that may increase their risk of exposure to botulinum toxin including diagnosed Myasthenia Gravis, Eaton-Lambert Syndrome, Amyotrophic Lateral Sclerosis, or any other disease that might interfere with neuromuscular function
  • History of facial nerve palsy
  • Allergy or sensitivity to any component of the study medication

结局指标

主要结局

The First Visit Onset of Efficacy as Measured by Subject Assessment

时间窗: 14 Days

The first visit onset of efficacy as measured by subject assessment. Onset is determined by a yes/no answer to the question "Since being injected, have you noticed any effect on the appearance of your frown lines (lines between the eyebrows)?" at days 2, 3, 4, 7, and 14.

The First Visit Onset of Efficacy as Measured by Physician Assessment

时间窗: 14 Days

The first visit onset of efficacy as measured by physician assessment. Onset is determined by a yes/no answer to the question "Since injecting the patient, have you noticed any effect on the appearance of the patient's frown lines (lines between the eyebrows)?" at days 2, 3, 4, 7, and 14.

次要结局

  • Average Subject Assessment Score in Improvement of Appearance of Frown Lines(14 Days)
  • Percentage of Patients Reporting Self-Perception of Age (SPA)(Baseline, Day 14)
  • Change From Baseline in Patient Satisfaction as Measured by Facial Line Outcome (FLO) Questionnaire Score(Baseline, Day 14)

研究者

发起方
Allergan
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验